GLP-1 RAs have emerged as powerful and multifaceted agents in managing metabolic disorders such as diabetes and obesity, and their utility is still expanding into areas that were previously beyond the scope of glycemic control. The gene discussed is GCG; the disease is Other metabolic disease.